178 related articles for article (PubMed ID: 8399083)
21. Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.
Kotze MJ; Peeters AV; Langenhoven E; Wauters JG; Van Gaal LF
Atherosclerosis; 1994 Dec; 111(2):217-25. PubMed ID: 7718024
[TBL] [Abstract][Full Text] [Related]
22. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
23. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
[TBL] [Abstract][Full Text] [Related]
24. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
25. [Influence of plasma lipids, APOE genotype and type of LDL receptor gene mutations on myocardial infarction in subjects with familial hypercholesterolemia].
Real JT; Ascaso JF; Chaves FJ; González C; Puig O; Armengod ME; Carmena R
Med Clin (Barc); 2002 May; 118(18):681-5. PubMed ID: 12042130
[TBL] [Abstract][Full Text] [Related]
26. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
28. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.
Leitersdorf E; Van der Westhuyzen DR; Coetzee GA; Hobbs HH
J Clin Invest; 1989 Sep; 84(3):954-61. PubMed ID: 2569482
[TBL] [Abstract][Full Text] [Related]
29. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
31. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
32. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
Soutar AK; McCarthy SN; Seed M; Knight BL
J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
[TBL] [Abstract][Full Text] [Related]
33. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
34. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
35. Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling.
Kotze MJ; Davis HJ; Bissbort S; Langenhoven E; Brusnicky J; Oosthuizen CJ
Clin Genet; 1993 Jun; 43(6):295-9. PubMed ID: 8370148
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia.
Jensen HK; Jensen LG; Meinertz H; Hansen PS; Gregersen N; Faergeman O
Atherosclerosis; 1999 Oct; 146(2):337-44. PubMed ID: 10532689
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population.
Yu W; Nohara A; Higashikata T; Lu H; Inazu A; Mabuchi H
Atherosclerosis; 2002 Dec; 165(2):335-42. PubMed ID: 12417285
[TBL] [Abstract][Full Text] [Related]
38. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
39. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia.
Santos PC; Morgan AC; Jannes CE; Turolla L; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2014 Mar; 233(1):206-10. PubMed ID: 24529145
[TBL] [Abstract][Full Text] [Related]
40. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
Friedlander Y; Leitersdorf E
Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
